WuXi PharmaTech has been awarded a certificate of Good Laboratory Practice (GLP) compliance for its toxicology facility in Suzhou, from the State Food and Drug Administration (SFDA), China’s regulatory authority. The certification covers single-dose and multiple-dose toxicology studies in both rodents and non-rodents, GeneTox studies, and toxicokinetic studies, and was issued following the SFDA’s review of WuXi’s management, personnel, test facilities, standard operating procedures, and...